SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Oct-13 8:52 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 30,250 | $125.00 | $3,781,250.00 | (94%) 32.08K to 1.83K | |
03-Oct-13 8:52 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition (change in control) | 1,833 | $125.00 | $229,125.00 | (100%) 1.83K to 0 | |
02-Jul-13 6:54 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 01-Jul-13 | Option Exercise | 25,375 | $28.55 | $724,456.00 | 79% 32.08K to 57.46K | |
02-Jul-13 6:54 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 01-Jul-13 | Market Option Sale (Planned) | 25,375 | $132.63 | $3,365,490.00 | (44%) 57.46K to 32.08K | 7% |
16-May-13 8:39 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 14-May-13 | Market Sale | 4,182 | $96.60 | $403,967.00 | (12%) 36.27K to 32.08K | (28%) |
03-Apr-13 7:52 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 01-Apr-13 | Market Sale (Planned) | 2,651 | $86.14 | $228,350.00 | (7%) 38.92K to 36.27K | (43%) |
01-Apr-13 7:39 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 28-Mar-13 | Grant | 7,100 | -- | -- | 22% 31.82K to 38.92K | |
05-Oct-12 7:32 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 05-Oct-12 | Market Sale (Planned) | 5,902 | $90.00 | $531,180.00 | (16%) 37.72K to 31.82K | (37%) |
27-Jul-12 8:25 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 25-Jul-12 | Market Sale (Planned) | 5,348 | $73.97 | $395,601.00 | (10%) 54.32K to 48.97K | (67%) |
05-Jul-12 6:03 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 02-Jul-12 | Disposition | 17,626 | $67.19 | $1,184,370.00 | (25%) 71.94K to 54.32K | (84%) |
05-Jul-12 6:03 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 02-Jul-12 | Option Exercise | 14,000 | $28.55 | $399,700.00 | 24% 57.94K to 71.94K | |
03-Apr-12 8:31 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 02-Apr-12 | Disposition | 2,208 | $36.58 | $80,761.60 | (4%) 60.15K to 57.94K | (238%) |
03-Apr-12 8:31 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 30-Mar-12 | Grant | 26,150 | -- | -- | 77% 34.0K to 60.15K | |
05-Jan-12 6:34 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 03-Jan-12 | Market Sale (Planned) | 1,232 | $42.64 | $52,532.50 | (3%) 35.23K to 34.0K | (190%) |
02-Sep-11 6:20 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 01-Sep-11 | Market Sale (Planned) | 1,006 | $34.14 | $34,344.80 | (3%) 36.24K to 35.23K | (262%) |
01-Aug-11 8:38 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 01-Aug-11 | Market Sale (Planned) | 1,665 | $33.27 | $55,394.60 | (4%) 37.9K to 36.24K | (271%) |
23-May-11 8:04 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 20-May-11 | Market Sale (Planned) | 594 | $43.02 | $25,555.40 | (2%) 37.83K to 37.24K | (187%) |
10-May-11 4:51 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 06-May-11 | Market Sale (Planned) | 3,783 | $40.00 | $151,320.00 | (9%) 41.62K to 37.83K | (209%) |
04-Apr-11 8:25 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 01-Apr-11 | Market Sale (Planned) | 1,478 | $35.02 | $51,759.60 | (3%) 43.09K to 41.62K | (253%) |
04-Apr-11 8:25 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 31-Mar-11 | Grant | 28,000 | -- | -- | 186% 15.09K to 43.09K | |
24-May-10 4:53 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 20-May-10 | Market Sale (Planned) | 600 | $24.06 | $14,438.70 | (4%) 14.46K to 13.86K | (414%) |
02-Apr-10 6:53 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 01-Apr-10 | Market Sale (Planned) | 739 | $30.10 | $22,243.90 | (5%) 15.2K to 14.46K | (311%) |
02-Apr-10 6:53 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 31-Mar-10 | Grant | 6,000 | -- | -- | 65% 9.2K to 15.2K | |
14-Aug-09 6:51 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 14-Aug-09 | Market Sale (Planned) | 3,182 | $30.73 | $97,782.90 | (26%) 12.38K to 9.2K | (303%) |
24-Jul-09 1:50 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 22-Jul-09 | Market Sale (Planned) | 8,828 | $35.98 | $317,642.00 | (42%) 21.21K to 12.38K | (242%) |
29-Jun-09 6:46 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 26-Jun-09 | Market Sale (Planned) | 3,332 | $26.27 | $87,533.30 | (14%) 24.54K to 21.21K | (369%) |
21-May-09 4:48 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 20-May-09 | Market Sale | 1,440 | $23.75 | $34,200.00 | (6%) 25.98K to 24.54K | (419%) |
02-Apr-09 7:50 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 31-Mar-09 | Grant | 6,000 | -- | -- | 40% 15.18K to 21.18K | |
02-Apr-09 7:50 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 12-Mar-09 | Grant | 4,800 | -- | -- | 23% 21.18K to 25.98K | |
10-Nov-08 8:22 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 06-Nov-08 | Payment of Exercise | 1,818 | $26.09 | $47,431.60 | (11%) 17.0K to 15.18K | (367%) |
20-May-08 4:14 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 19-May-08 | Grant | 17,000 | -- | -- | 100% 0 to 17.0K | |
15-Jun-06 1:33 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 14-Jun-06 | Market Purchase | 10,600 | $4.74 | $50,244.00 | 110% 9.62K to 20.22K | 505% |
11-May-06 1:24 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 10-May-06 | Market Purchase | 9,620 | $5.20 | $50,024.00 | 100% 0 to 9.62K | 451% |